In the rapidly evolving landscape of diabetes treatment, GLP-1 peptide prescriptions are becoming increasingly common. Nonetheless, the rise in demand for these potent medications necessitates robust safeguards to prevent illegitimate activity. Medical facilities play a crucial role in ensuring the integrity of GLP-1 peptide prescriptions by implem